(Total Views: 526)
Posted On: 10/14/2020 3:29:10 PM
Post# of 36541
Not that I understood. I thought their PR said they "received" the $2.65M.
https://storage.googleapis.com/wzukusers/user...7_2020.pdf
NuGenerex Immuno-Oncology has received the upfront licensing fee of $2.625 million
In exchange for the license and distribution exclusivity, Bintai has paid an up-front licensing fee
of $2.625 million and has committed to funding 100% of the commercial development costs for
the Ii-Key-CoV-2 vaccine including laboratory and pre-clinical work,
https://storage.googleapis.com/wzukusers/user...7_2020.pdf
NuGenerex Immuno-Oncology has received the upfront licensing fee of $2.625 million
In exchange for the license and distribution exclusivity, Bintai has paid an up-front licensing fee
of $2.625 million and has committed to funding 100% of the commercial development costs for
the Ii-Key-CoV-2 vaccine including laboratory and pre-clinical work,
(1)
(0)
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼
